Examination of the current top candidate genes for AD in a genome-wide association study

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Haploview: analysis and visualization of LD and haplotype maps

Barrett, J., Fry, B., Maller, J., & Daly, M. (2005) · Bioinform. · doi:10.1093/bioinformatics/bth457 · Cited by 15,086 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

The Structure of Haplotype Blocks in the Human Genome

Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., et al. (2002) · Science · doi:10.1126/science.1069424 · Cited by 5,863 · see citing works

A haplotype map of the human genome

The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia

Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · see citing works

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · see citing works

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951 · see citing works

Common deletion polymorphisms in the human genome

McCarroll, S. A., Hadnott, T. N., Perry, G. H., Sabeti, P. C., Zody, M. C., Barrett, J. C., Dallaire, S., Gabriel, S. B., Lee, C., Daly, M. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1696 · Cited by 701 · see citing works

A genome-wide scalable SNP genotyping assay using microarray technology

Gunderson, K. L., Steemers, F. J., Lee, G., Mendoza, L., & Chee, M. S. (2005) · Nature Genetics · doi:10.1038/ng1547 · Cited by 655 · see citing works

A high-resolution survey of deletion polymorphism in the human genome

Conrad, D. F., Andrews, T. D., Carter, N. P., Hurles, M. E., & Pritchard, J. K. (2005) · Nature Genetics · doi:10.1038/ng1697 · Cited by 653 · see citing works

Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q

Bertram, L., Blacker, D., Mullin, K., Keeney, D. B., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519 · see citing works

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

Li, H., Wetten, S., Li, L., St. Jean, P. L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M. R., Briley, J. D., Borrie, M., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.3 · Cited by 499 · see citing works

GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers

Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.022 · Cited by 487 · see citing works

Susceptibility Locus for Alzheimer's Disease on Chromosome 10

Myers, A., Holmans, P., Marshall, H. N., Kwon, J. M., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVriéze, F. W., Crook, R., et al. (2000) · Science · doi:10.1126/science.290.5500.2304 · Cited by 385 · see citing works

Whole-genome genotyping with the single-base extension assay

Steemers, F. J., Chang, W., Lee, G., Barker, D. L. A., Shen, R., & Gunderson, K. L. (2005) · Nature Methods · doi:10.1038/nmeth842 · Cited by 378 · see citing works

Common deletions and SNPs are in linkage disequilibrium in the human genome

Hinds, D. A., Kloek, A. P., Jen, M., Chen, X., & Frazer, K. A. (2006) · Nature Genetics · doi:10.1038/ng1695 · Cited by 372 · see citing works

Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees

Ertekin‐Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C. B., Baker, M., Adamson, J. L., Ronald, J., Blangero, J., Hutton, M. L., & Younkin, S. G. (2000) · Science · doi:10.1126/science.290.5500.2303 · Cited by 370 · see citing works

SNPing Away at Complex Diseases: Analysis of Single-Nucleotide Polymorphisms around APOE in Alzheimer Disease

Martin, E. R., Lai, E., Gilbert, J. R., Rogala, A. R., Afshari, A. J., Riley, J., Finch, K., Stevens, J., Livak, K., Slotterbeck, B. D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303003 · Cited by 358 · see citing works

Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled

Li, Y.-J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339815 · Cited by 312 · see citing works

The Number of Trait Loci in Late-Onset Alzheimer Disease

Daw, E. W., Payami, H., Nemens, E. J., Nochlin, D., Bird, T. D., Schellenberg, G. D., & Wijsman, E. M. (2000) · The American Journal of Human Genetics · doi:10.1086/302710 · Cited by 295 · see citing works

Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants

Grupe, A., Abraham, R., Li, Y., Rowland, C., Hollingworth, P., Morgan, A., Jehu, L., Segurado, R., Stone, D., Schadt, E., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm031 · Cited by 289 · see citing works

APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

Sando, S. B., Melquist, S., Cannon, A., Hutton, M. L., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. O. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-9 · Cited by 261 · see citing works

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

Myers, A., Pittman, A. M., Zhao, A. S., Rohrer, K., Kaleem, M. A., Marlowe, L., Lees, A. J., Leung, D. G., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.018 · Cited by 254 · see citing works

The H1c haplotype at the MAPT locus is associated with Alzheimer's disease

Myers, A. J., Kaleem, M., Marlowe, L., Pittman, A. M., Lees, A. J., Fung, H., Duckworth, J., Leung, D. G., Gibson, A., Morris, C. M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi241 · Cited by 221 · see citing works

Full genome screen for Alzheimer disease: Stage II analysis*

Myers, A., DeVriéze, F. W., Holmans, P., Hamshere, M. L., Crook, R., Compton, D., Marshall, H. N., Meyer, D., Shears, S., Booth, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10183 · Cited by 206 · see citing works

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association

Yu, C., Seltman, H. J., Peskind, E. R., Galloway, N. M., Zhou, P. X., Rosenthal, E. A., Wijsman, E. M., Tsuang, D. W., Devlin, B., & Schellenberg, G. D. (2007) · Genomics · doi:10.1016/j.ygeno.2007.02.002 · Cited by 155 · see citing works

The Association Between Genetic Variants in SORL1 and Alzheimer Disease in an Urban, Multiethnic, Community-Based Cohort

Lee, J. H., Cheng, R., Schupf, N., Manly, J. J., Lantigua, R., Stern, Y., Rogaeva, E. A., Wakutani, Y., Farrer, L. A., George‐Hyslop, P. S., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.501 · Cited by 143 · see citing works

Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease

Finckh, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.11.1579 · Cited by 142 · see citing works

Alzheimer’s disease: Insights from epidemiology

McDowell, I. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351474 · Cited by 141 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population

Bettens, K., Brouwers, N., Engelborghs, S., Deyn, P. P. D., Broeckhoven, C. V., & Sleegers, K. (2008) · Human Mutation · doi:10.1002/humu.20725 · Cited by 97 · see citing works

Diabetes mellitus, dementia, and cognitive function in older persons.

Arvanitakis, Z., Wilson, R. S., & Bennett, D. A. (2006) · PubMed · Cited by 79 · see citing works

ASSOCIATION BETWEEN GENETIC VARIANTS IN SORL1 AND AUTOPSY-CONFIRMED ALZHEIMER DISEASE

Lee, J. H., Cheng, R., Honig, L. S., Vonsattel, J.-P., Clark, L. N., & Mayeux, R. P. (2007) · Neurology · doi:10.1212/01.wnl.0000280581.39755.89 · Cited by 73 · see citing works

Apolipoprotein E genotypes and age of onset in early‐onset familial Alzheimer's disease

Levy‐Lahad, E., Lahad, A., Wijsman, E. M., Bird, T. D., & Schellenberg, G. D. (1995) · Annals of Neurology · doi:10.1002/ana.410380420 · Cited by 70 · see citing works

Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease

Laws, S. M., Friedrich, P., Diehl‐Schmid, J., Müller, J., Eisele, T., Bäuml, J., Förstl, H., Kurz, A., & Riemenschneider, M. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001935 · Cited by 68 · see citing works

Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease

Papassotiropoulos, A., Lambert, J., Vrièze, F. W., Wollmer, M. A., von der Kammer, H., Streffer, J. R., Maddalena, A. S., Huynh, K.-D., Wolleb, S., Lütjohann, D., et al. (2005) · Neurodegenerative Diseases · doi:10.1159/000090362 · Cited by 64 · see citing works

Promoter Polymorphism in PCK1 (Phosphoenolpyruvate Carboxykinase Gene) Associated with Type 2 Diabetes Mellitus

Cao, H., van der Veer, E., Ban, M. R., Hanley, A. J., Zinman, B., Harris, S. B., Young, T. K., Pickering, J. G., & Hegele, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031361 · Cited by 57 · see citing works

Haplotype-based association analysis of the MAPT locus in Late Onset Alzheimer's disease

Mukherjee, O., Kauwe, J. S., Mayo, K., Morris, J. C., & Goate, A. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-3 · Cited by 52 · see citing works

Cystatin C as a risk factor for Alzheimer disease

Cathcart, H. M., Huang, R., Lanham, I. S., Corder, E. H., & Poduslo, S. E. (2005) · Neurology · doi:10.1212/01.wnl.0000151980.42337.44 · Cited by 49 · see citing works

Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease

Cook, L. J., Ho, L. W., Taylor, A., Brayne, C., Evans, J. G., Xuereb, J. H., Cairns, N. J., Pritchard, A. L., Lemmon, H. A., Mann, D. M. A., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.016 · Cited by 44 · see citing works

Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease

Kölsch, H., Jessen, F., Wiltfang, J., Lewczuk, P., Dichgans, M., Kornhuber, J., Frölich, L., Heuser, I., Peters, O., Schulz, J. B., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.049 · Cited by 40 · see citing works

Gene identification in Alzheimer’s disease

Saunders, A. M. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.239 · Cited by 28 · see citing works

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD

Dodel, R. C., Du, Y., Depboylu, C., Kurz, A., Eastwood, B. J., Farlow, M. R., Oertel, W., Müller, U., & Riemenschneider, M. J. (2002) · Neurology · doi:10.1212/wnl.58.4.664 · Cited by 26 · see citing works

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer’s disease

Riemenschneider, M. J., Mahmoodzadeh, S., Eisele, T., Klopp, N., Schwarz, S., Wagenpfeil, S., Diehl, J., Mueller, U., Foerstl, H., Illig, T., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.001 · Cited by 19 · see citing works

Efficacy assessment of SNP sets for genome-wide disease association studies

Wollstein, A., Herrmann, A., Wittig, M., Nothnagel, M., Franke, A., Nürnberg, P., Schreiber, S., Krawczak, M., & Hampe, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm621 · Cited by 15 · see citing works

Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease

Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219 · see citing works

Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes

Jun, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.201 · Cited by 422 · see citing works

Alzheimer’s Disease: An Updated Overview of Its Genetics

Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336 · see citing works

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE

Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285 · see citing works

Genetics of familial and sporadic Alzheimer s disease

Piaceri, I. (2013) · Frontiers in Bioscience · doi:10.2741/e605 · Cited by 256 · see citing works

Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?

Mullane, K., & Williams, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 212 · see citing works

Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals

Lee, J. H., Cheng, R., Barral, S., Reitz, C., Medrano, M., Lantigua, R., Jiménez-Velazquez, I. Z., Rogaeva, E., St. George-Hyslop, P. H., & Mayeux, R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.292 · Cited by 190 · see citing works

Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease

Reitz, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.346 · Cited by 162 · see citing works

Angiotensins in Alzheimer's disease – friend or foe?

Kehoe, P. G., Miners, J. S., & Love, S. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.07.006 · Cited by 166 · see citing works

Research Progress in the Pathogenesis of Alzheimer's Disease

Chen, Y. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.235112 · Cited by 139 · see citing works

Genetics of Alzheimer's disease: new evidences for an old hypothesis?

Lambert, J., & Amouyel, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.002 · Cited by 132 · see citing works

Genetics of Alzheimer’s Disease

Vilatela, M. E. A., López, M., & Yescas, P. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.017 · Cited by 129 · see citing works

Genetic architecture of Alzheimer's disease

Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126 · see citing works

Methionine-35 of A <i>β</i> (1–42): Importance for Oxidative Stress in Alzheimer Disease

Butterfield, D. A., & Sultana, R. (2011) · Journal of Amino Acids · doi:10.4061/2011/198430 · Cited by 124 · see citing works

Opening Pandora‘s Jar: A Primer on the Putative Roles of Crmp2 In A Panoply of Neurodegenerative, Sensory and Motor Neuron, and Central Disorders

Khanna, R., Wilson, S. M., Brittain, J. M., Weimer, J. M., Rukhsana Sultana, A., Butterfield, D. A., & Hensley, K. (2012) · Future Neurology · doi:10.2217/fnl.12.68 · Cited by 112 · see citing works

A decade in psychiatric GWAS research

Horwitz, T. B., Lam, K., Chen, Y., Xia, Y., & Liu, C. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0055-z · Cited by 103 · see citing works

Genetics of Alzheimer disease in the pre- and post-GWAS era

Ertekin‐Taner, N. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt26 · Cited by 107 · see citing works

Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease

Qiu, W., Guo, X., Lin, X., Yang, Q., Zhang, W., Zhang, Y., Zuo, L., Zhu, Y., Li, C.-S. R., Ma, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.020 · Cited by 105 · see citing works

Association and Expression Analyses With Single-Nucleotide Polymorphisms in TOMM40 in Alzheimer Disease

Cruchaga, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.155 · Cited by 104 · see citing works

Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies

Liu, G., Yao, L., Liu, J., Jiang, Y., Ma, G., Chen, Z., Zhao, B., & Li, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.084 · Cited by 102 · see citing works

Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE

Bekris, L. M., Lutz, F., & Yu, C. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.123 · Cited by 98 · see citing works

Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics

Kim, D. K., Park, J., Han, D., Yang, J., Kim, A., Woo, J., Kim, Y., & Mook-Jung, I. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0234-4 · Cited by 95 · see citing works

Oxidative Modification of Brain Proteins in Alzheimer's Disease: Perspective on Future Studies Based on Results of Redox Proteomics Studies

Rukhsana Sultana, A., & Butterfield, D. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129018 · Cited by 83 · see citing works

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants

Mayeux, R. P., & Schupf, N. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.004 · Cited by 79 · see citing works

Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study

Sweet, R. A., Bennett, D. A., Graff‐Radford, N. R., & Mayeux, R. P. (2010) · Brain · doi:10.1093/brain/awq001 · Cited by 74 · see citing works

Alzheimer’s disease diagnosis from multi-modal data via feature inductive learning and dual multilevel graph neural network

Lei, B., Li, Y., Fu, W., Yang, P., Chen, S., Wang, T., Xiao, X., Niu, T., Fu, Y., Wang, S., et al. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103213 · Cited by 73 · see citing works

Systematic Analysis of Candidate Genes for Alzheimer's Disease in a French, Genome-Wide Association Study

Laumet, G. O., Chouraki, V. A., Grenier‐Boley, B., Legry, V., Heath, S. C., Zélénika, D., Fiévet, N., Hannequin, D., Délepine, M., Pasquier, F., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100126 · Cited by 71 · see citing works

Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 70 · see citing works

Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale

Ruffini, N., Klingenberg, S., Schweiger, S., & Gerber, S. (2020) · Cells · doi:10.3390/cells9122642 · Cited by 65 · see citing works

Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

Zetzsche, T., Rujescu, D., Hardy, J., & Hampel, H. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.48 · Cited by 61 · see citing works

The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease

Gerrish, A., Russo, G., Richards, A. L., Moskvina, V., Ivanov, D. K., Harold, D. H., Sims, R., Abraham, R., Hollingworth, P., Chapman, J., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110824 · Cited by 61 · see citing works

Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease

Belbin, O., Carrasquillo, M. M., Crump, M., Culley, O. J., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., Allen, M., Dickson, D. W., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0924-2 · Cited by 58 · see citing works

Genetics of Late‐Onset Alzheimer′s Disease: Update from the Alzgene Database and Analysis of Shared Pathways

Olgiati, P., Politis, A. M., Papadimitriou, G. N., Ronchi, D. D., & Serretti, A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/832379 · Cited by 57 · see citing works

Recent insights into the molecular genetics of dementia

Rademakers, R., & Rovelet‐Lecrux, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.005 · Cited by 55 · see citing works

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Ashby, E. L., & Kehoe, P. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.812631 · Cited by 54 · see citing works

Alcohol Sensitivity in Drosophila: Translational Potential of Systems Genetics

Morozova, T. V., Ayroles, J. F., Jordan, K. W., Duncan, L. H., Carbone, M. A., Lyman, R. F., Stone, E. A., Govindaraju, D. R., Ellison, R. C., Mackay, T. F. C., et al. (2009) · Genetics · doi:10.1534/genetics.109.107490 · Cited by 52 · see citing works

Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease

Kauwe, J. S. K., Bertelsen, S. E., Mayo, K., Cruchaga, C., Abraham, R., Hollingworth, P., Harold, D. H., Owen, M. J., Williams, J. H., Lovestone, S., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31053 · Cited by 53 · see citing works

Gene-Centric Analysis Identifies Variants Associated With Interleukin-6 Levels and Shared Pathways With Other Inflammation Markers

Shah, T., Zabaneh, D., Gaunt, T. R., Swerdlow, D. I., Shah, S. H., Talmud, P. J., Day, I. N. M., Whittaker, J. C., Holmes, M. V., Sofat, R., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.964254 · Cited by 51 · see citing works

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases

Zhang, C., Zhu, J., Wan, Y., Tan, L., Wang, H.-F., Yu, J., & Tan, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16690 · Cited by 53 · see citing works

Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1

Wang, Z., Lei, H., Zheng, M., Li, Y., Cui, Y., & Hao, F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9546-y · Cited by 49 · see citing works

From beta amyloid to altered proteostasis in Alzheimer’s disease

Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47 · see citing works

The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age

Ferencz, B., Laukka, E. J., Lövdén, M., Kalpouzos, G., Keller, L., Graff, C., Wahlund, L., Fratiglioni, L., & Bäckman, L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00198 · Cited by 44 · see citing works

Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine

Flood, D. G., Marek, G. J., & Williams, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.021 · Cited by 45 · see citing works

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives

Casallas, J. C. G., & Bustos, R. (2018) · Brain Sciences · doi:10.3390/brainsci8120222 · Cited by 47 · see citing works

Variants in <i>PPP3R1</i> and <i>MAPT</i> are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study

Peterson, D., Munger, C., Crowley, J., Corcoran, C., Cruchaga, C., Goate, A. M., Norton, M. C., Green, R. C., Munger, R. G., Breitner, J. C. S., et al. (2014) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2013.02.010 · Cited by 44 · see citing works

Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease

Shulman, J. M., Chibnik, L. B., Aubin, C., Schneider, J. A., Bennett, D., & Jager, P. L. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011244 · Cited by 46 · see citing works

Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer’s Disease

Sassi, C., Ridge, P. G., Nalls, M. A., Gibbs, J. R., Ding, J., Lupton, M. K., Troakes, C., Lunnon, K., Al‐Sarraj, S., Brown, K. S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150079 · Cited by 42 · see citing works

State of Play in Alzheimer’s Disease Genetics

Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 43 · see citing works

Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals

Shang, Z., Lv, H., Zhang, M., Duan, L., Wang, S., Li, J., Liu, G., Zhang, R., & Jiang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6391 · Cited by 43 · see citing works

The SORL1 gene and convergent neural risk for Alzheimer’s disease across the human lifespan

Felsky, D., Szeszko, P. R., Yu, L., Honer, W. G., Jager, P. L. D., Schneider, J. A., Malhotra, A. K., Lencz, T., Ikuta, T., Pipitone, J., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.142 · Cited by 42 · see citing works

The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis

Zhang, Y., Li, X.-B., Zhang, J., Huang, J., He, C. S., Tian, C., Deng, Y., Wan, H., Shrestha, D., Yang, Y., et al. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02438.x · Cited by 41 · see citing works

Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers

Alexopoulos, P., Guo, L., Kratzer, M., Westerteicher, C., Kurz, A., Perneczky, R., & Initiative, A. D. N. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000332017 · Cited by 41 · see citing works

Whole genome association studies in complex diseases: where do we stand?

Need, A. C., & Goldstein, D. B. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/aneed · Cited by 40 · see citing works

Sortilin receptor 1 predicts longitudinal cognitive change

Reynolds, C. A., Zavala, C., Gatz, M., Vie, L. L., Johansson, B. E. A., Malmberg, B., Ingelsson, E., Prince, J. A., & Pedersen, N. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.006 · Cited by 40 · see citing works

Genetics and epigenetics of Alzheimer's disease

Alagiakrishnan, K., Gill, S. S., & Fagarasanu, A. D. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130363 · Cited by 38 · see citing works

SORL1 is Genetically Associated with Neuropathologically Characterized Late-Onset Alzheimer's Disease

Wen, Y., Initiative, J. A. D. N., Miyashita, A., Kitamura, N., Tsukie, T., Saito, Y., Hatsuta, H., Murayama, S., Kakita, A., Takahashi, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122395 · Cited by 37 · see citing works

The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis

Zhang, Y., He, J., Deng, Y. L., Zhang, J., Li, X., Xiang, Z., Huang, H., Tian, C., Huang, J., & Fan, H. X. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-159 · Cited by 36 · see citing works

The associations between the MAPT polymorphisms and Alzheimer’s disease risk: a meta-analysis

Zhou, F., & Wang, D. (2017) · Oncotarget · doi:10.18632/oncotarget.16490 · Cited by 34 · see citing works

Genetic Variants and Oxidative Stress in Alzheimer’s Disease

Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 34 · see citing works

Association of interleukin 1β polymorphisms and haplotypes with Alzheimer's disease.

Payão, S., Gonçalves, G., de Lábio, R. D., Horiguchi, L., Mizumoto, I., Rasmussen, L., Pinhel, M. A. D. S., Souza, D. R. S., Bechara, M., Chen, E., et al. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.012 · Cited by 33 · see citing works

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review

Vogrinc, D., Goričar, K., & Dolžan, V. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646901 · Cited by 32 · see citing works

Gene Expression Profiling of Peripheral Blood Leukocytes Shows Consistent Longitudinal Downregulation of TOMM40 and Upregulation of KIR2DL5A, PLOD1, and SLC2A8 Among Fast Progressors in Early Alzheimer's Disease

Chong, M. S., Goh, L. K., Lim, W. S., Chan, M., Tay, L. B. G., Chen, G., Feng, L., Ng, T. P., Tan, C. H., & Lee, T.-S. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121621 · Cited by 32 · see citing works

Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence ofAPOEandTOMM40on Brain Integrity

Ferencz, B., Karlsson, S., & Kalpouzos, G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/421452 · Cited by 32 · see citing works

Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer’s Disease: Dietary Plant Polyphenols

Wang, Y., Wang, K., Yan, J., Zhou, Q., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213886 · Cited by 29 · see citing works

SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease

Guo, L., Westerteicher, C., Wang, X., Kratzer, M., Tsolakidou, A. F., Jiang, M., Grimmer, T., Laws, S. M., Alexopoulos, P., Bujo, H., et al. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0295-x · Cited by 28 · see citing works

Genetic variation associated with the occurrence and progression of neurological disorders

Little, J., Barakat, C., Martino, R., Pringsheim, T. M., Tremlett, H. L., McKay, K. A., Lieshout, P. H. H. M. V., Walsh, S. J., Gomes, J., & Krewski, D. R. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.09.018 · Cited by 28 · see citing works

Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease?

Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26 · see citing works

An age effect on the association of common variants of ACE with Alzheimer's disease

Helbecque, N., Codron, V., Cottel, D., & Amouyel, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.006 · Cited by 26 · see citing works

Diabetes, Insulin and Alzheimer's Disease

Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24 · see citing works

Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers

Liang, W. S., Chen, K., Lee, W., Sidhar, K., Corneveaux, J. J., Allen, A. N., Myers, A., Villa, S., Meechoovet, B., Pruzin, J. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.066 · Cited by 23 · see citing works

Elucidating novel dysfunctional pathways in Alzheimer's disease by integrating loci identified in genetic and epigenetic studies

Smith, A. R., Mill, J. S., Smith, R. G., & Lunnon, K. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.05.001 · Cited by 21 · see citing works

Lessons from genome‐wide association studies findings in Alzheimer's disease

Moraes, C. F., Lins, T. C. D. L., CARMARGOS, E. F., Naves, J. O. S., Pereira, R. W., & Nóbrega, O. D. T. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00378.x · Cited by 19 · see citing works

TOMM40 Alterations in Alzheimer's Disease Over a 2-Year Follow-Up Period

Goh, L. K., Lim, W. S., Teo, S. R., Vijayaraghavan, A., Chan, M. Y., Tay, L. B. G., Ng, T. P., Tan, C. H., Lee, T.-S. W., & Chong, M. S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141590 · Cited by 20 · see citing works

Sociodemographic characteristics, clinical factors, and genetic polymorphisms associated with Alzheimer's disease

Bicalho, M. A. C., Pimenta, F. A. P., Bastos‐Rodrigues, L., Hansen, É. D. O., Neves, S. C., Melo, M., Rosa, D. V., de Souza, R. P., de Miranda, D. M., de Moraes, E. N., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3875 · Cited by 20 · see citing works

Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer’s Disease

Yin, Y., Liu, Y., Pan, X., Chen, R., Li, P., Wu, H., Zhao, Z., Li, Y.-P., Huang, L., Zhuang, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149945 · Cited by 20 · see citing works

Genome-wide significant, replicated and functional risk variants for Alzheimer’s disease

Guo, X., Qiu, W., García-Milian, R., Lin, X., Zhang, Y., Cao, Y., Tan, Y., Wang, Z., Shi, J., Wang, J., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1773-0 · Cited by 19 · see citing works

Association of TOMM40 and SLC22A4 polymorphisms with ischemic stroke

Yamase, Y., Horibe, H., Ueyama, C., Fujimaki, T., Oguri, M., Kato, K., Arai, M., Watanabe, S., & Yamada, Y. (2015) · Biomedical Reports · doi:10.3892/br.2015.457 · Cited by 16 · see citing works

Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 Diabetes

Kong, X., Zhao, Q., Xing, X., Zhang, B., Zhang, X., Hong, J., & Yang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135145 · Cited by 16 · see citing works

Replicative association analysis of genetic markers of cognitive traits with Alzheimer’s disease in the Russian population

Степанов, В. А., Бочарова, А. В., Marusin, A. V., Жукова, Н. Г., Alifirova, V. M., & Zhukova, I. A. (2014) · Molecular Biology · doi:10.1134/s0026893314060168 · Cited by 16 · see citing works

Unraveling the biological mechanisms in Alzheimer's disease — Lessons from genomics

Borovečki, F., Klepac, N., Mück‐Šeler, D., Hajnšek, S., Mubrin, Z., & Pivac, N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.019 · Cited by 15 · see citing works

A current view of Alzheimer's disease

Hooli, B. V., & Tanzi, R. E. (2009) · F1000 Biology Reports · doi:10.3410/b1-54 · Cited by 14 · see citing works

The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach

Ruffini, N., Klingenberg, S., Heese, R., Schweiger, S., & Gerber, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.866886 · Cited by 14 · see citing works

Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk

Simmons, C. R., Zou, F., Younkin, S. G., & Estus, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-62 · Cited by 15 · see citing works

DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort

Vázquez‐Higuera, J. L., Sánchez‐Juan, P., Rodríguez‐Rodríguez, E., Mateo, I., Pozueta, A., Frank, A., Sastre, I., Valdivieso, F., Berciano, J., Bullido, M. J., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-129 · Cited by 14 · see citing works

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology

Zou, F., Belbin, O., Carrasquillo, M. M., Culley, O. J., Hunter, T. A., Ma, L., Bisceglio, G. D., Allen, M., Dickson, D. W., Graff‐Radford, N. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064802 · Cited by 13 · see citing works

Angiotensin-converting enzyme polymorphisms AND Alzheimer’s disease susceptibility: An updated meta-analysis

Xin, X., Lai, Z.-H., Ding, K.-Q., Zeng, L., & Ma, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260498 · Cited by 13 · see citing works

A lzheimer's Disease Biomarkers: More Than Molecular Diagnostics

Anderson, D. C. (2013) · Drug Development Research · doi:10.1002/ddr.21073 · Cited by 9 · see citing works

Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders

Prendecki, M., Kowalska, M., Totoń, E., & Kozubski, W. P. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200422152440 · Cited by 10 · see citing works

Smoothed quantile regression for partially functional linear models in high dimensions

Wang, Z., Bai, Y., Härdle, W. K., & Tian, M. (2023) · Biometrical Journal · doi:10.1002/bimj.202200060 · Cited by 9 · see citing works

Impact of SORL1 genetic variations on MRI markers in non-demented elders

Yin, R., Initiative, A. D. N., Li, J., Tan, L., Wang, H.-F., Tan, M., Yu, W.-J., Tan, C., Yu, J., & Tan, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9300 · Cited by 9 · see citing works

Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer’s disease: a meta-analysis

Wang, X., Cui, N., Gao, J.-J., Qiu, X., Yang, N., & Zheng, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1235-x · Cited by 8 · see citing works

Genome-wide association studies: a powerful tool for neurogenomics

Cowperthwaite, M. C., Mohanty, D., & Burnett, M. G. (2009) · Neurosurgical FOCUS · doi:10.3171/2010.10.focus09186 · Cited by 8 · see citing works

Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease

Ma, S. L., & LAM, L. C. W. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.54 · Cited by 8 · see citing works

The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease.

Chou, C., & Yeh, H. (2014) · Europe PMC (PubMed Central) · Cited by 8 · see citing works

Association of microtubule-associated protein tau gene polymorphisms with the risk of sporadic Alzheimer's disease: a meta-analysis

Yuan, H. D., Du, L., Ge, P., Wang, X., & Xia, Q. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1400972 · Cited by 8 · see citing works

Caspase-1 genetic variation is not associated with Alzheimer's disease risk

Vázquez‐Higuera, J. L., Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., Mateo, I., Pozueta, A., Martı́nez-Garcı́a, A., Frank, A., Valdivieso, F., Berciano, J., Bullido, M. J., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-32 · Cited by 8 · see citing works

Synergistic Effect between the APOE ε4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease

Toral-Ríos, D., Pichardo‐Rojas, P. S., Ruiz-Sánchez, E., Rosas‐Carrasco, Ó., Carvajal-García, R., Gálvez-Coutiño, D. C., Martínez‐Rodríguez, N., Rubio-Chávez, A. D., Alcántara-Flores, M., López-Ramírez, A. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810228 · Cited by 6 · see citing works

Historical perspectives on the discovery and development of drugs to treat neurological disorders

Williams, M. J., & COYLE, J. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.008 · Cited by 6 · see citing works

LLR: a latent low-rank approach to colocalizing genetic risk variants in multiple GWAS

Liu, J., Wan, X., Wang, C., Yang, C., Zhou, X., & Yang, C. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx512 · Cited by 6 · see citing works

Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer’s disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype

Leko, M. B., Španić, E., Willumsen, N., Perković, M. N., Pleić, N., Zubčić, K., Horvat, L. L., Vogrinc, Ž., Boban, M., Borovečki, F., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1456670 · Cited by 5 · see citing works

P4‐124: An examination of previously reported Alzheimer candidate genes within a large genome‐wide association dataset

Gerrish, A., Harold, D. H., Sims, R., Abraham, R., Hollingworth, P., Hamshere, M. L., Lovestone, S., Brayne, C., Gill, M., LAWLOR, B. A., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.792

S1‐03‐06: Is it real? the short history of genome‐wide association findings in Alzheimer's disease

Bertram, L. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.199

Power and Pitfalls of the Genome-Wide Association Study Approach to Identify Genes for Alzheimer’s Disease

Sherva, R., & Farrer, L. A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0184-4 · Cited by 31 · see citing works

Lessons from genome‐wide association studies findings in Alzheimer's disease

Moraes, C. F., Lins, T. C. D. L., CARMARGOS, E. F., Naves, J. O. S., Pereira, R. W., & Nóbrega, O. D. T. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00378.x · Cited by 19 · see citing works

IC‐P‐173: EFFECTS OF NEWLY IDENTIFIED TOP AD CANDIDATE GENES ON MEMORY PERFORMANCE: SNP, GENE, AND EPISTASIS ANALYSES IN ADNI

Yan, J., Kim, S., Nho, K. T., Risacher, S. L., Moore, J. H., Saykin, A. J., Shen, L., & ADNI, A. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.180